CClinicalTrials.gg
RecruitingNCT06532422NEPHRAMBUUpdated Apr 1, 2026

Study of Post-operative Complications After Laparoscopic Outpatient Nephrectomy

An observational study in Kidney Cancer, sponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-01.

Sponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche · Observational

From the registry’s dates

  • Started Dec 2024; still recruiting 1 year 9 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
50
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to compare to assess the incidence of post-operative complications related to nephrectomy, which occur up to 1 month after the operation.

Read the detailed description

This is an observational, prospective, open, non-comparative (single arm), single-centre study.

The study population consisted of adult patients diagnosed with localised kidney cancer and scheduled for outpatient partial or total laparoscopic nephrectomy.

Patients eligible for outpatient surgery will be identified during the initial consultation with the urological surgeon. When the indication for surgery has been validated at the multidisciplinary consultation meeting and is planned to be performed as an outpatient procedure, the study will be proposed to the patient by the investigator during the preoperative consultation.

02

Conditions studied

  • Kidney Cancer

Browse trials for

03

In context

Kidney Neoplasms

956 studies on the registry are indexed under Kidney Neoplasms; 210 are open to participants now.

This study's planned enrollment of 50 is below the median of 218 across 216 observational studies indexed under Kidney Neoplasms.

Browse Kidney Neoplasms studies →

Lead sponsor

GCS Ramsay Santé pour l'Enseignement et la Recherche is the lead sponsor of 198 studies on the registry; 94 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Probability sample

Study population

Adult patients diagnosed with localised kidney cancer, undergoing scheduled surgery for partial or total laparoscopic nephrectomy on an outpatient basis.

Inclusion criteria

  • Patients over 18 ;
  • Localised kidney cancer ;
  • Validation of curative treatment at a multidisciplinary consultation meeting;
  • Partial or total laparoscopic nephrectomy scheduled on an outpatient basis;
  • Membership of a social security scheme or receiving State Medical Aid;
  • Patient able to understand the information relating to the study, to read the information leaflet and who has given his/her oral non-objection.

Exclusion criteria

Exclusion Criteria:

  • Emergency intervention ;
  • Patient not eligible for outpatient treatment;
  • Long-term curative anti-coagulant treatment ;
  • Resident more than 100km from the clinic;
  • Home alone on the first night;
  • Patient of protected age (under guardianship or curatorship, or deprived of liberty).
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
50 participants (estimated)
Patient registry
No

Groups and cohorts

  • cohort of outpatients

    Adult patients diagnosed with localised kidney cancer, undergoing scheduled surgery for partial or total laparoscopic nephrectomy on an outpatient basis.

    Procedure: Partial or total laparoscopic nephrectomy

Interventions

  • ProcedurePartial or total laparoscopic nephrectomy

    Nephrectomy is currently the primary indication for localised kidney cancer. All patients consulting a surgeon at the Clinique de la Sauvegarde for localised kidney cancer, for which surgical excision has been validated by the multidisciplinary consultation meeting and who are eligible for outpatient treatment, will be offered the opportunity to take part in this study during the preoperative consultation.

06

What researchers measure

Primary outcomes

  1. Incidence of complications

    The study will observe the incidence and describe the type, number, severity, duration and frequency of complications that may arise in the immediate post-operative period following ambulatory nephrectomy.

    Time frame: 1 month

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06532422
Lead sponsor
GCS Ramsay Santé pour l'Enseignement et la Recherche
Collaborators
Euraxi Pharma
Responsible party
Sponsor
First posted
Aug 1, 2024
Start date
Dec 13, 2024
Primary completion
Sep 2026 (estimated)
Completion
Sep 2026 (estimated)
Last update
Apr 1, 2026

Study contacts

Arnaud MD BALDINI
Contact
docteur.baldini@urolyon-ouest.fr
469001019 ext. +33

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion